UN STI Forum - Urias

download UN STI Forum - Urias

of 11

Transcript of UN STI Forum - Urias

  • 7/26/2019 UN STI Forum - Urias

    1/11

    The meeting of STI systems, catching up in termsof industrial capabilities in pharmaceuticals and

    access to medicines.Dr. Eduardo UriasMulti-stakeholder Forum on Science, Technology and Innovation for the SDGs

    6-7 June 2016, UN Headquarters, New York

  • 7/26/2019 UN STI Forum - Urias

    2/11

    SDGs and Health

    06-06-16 [email protected] - STI Forum, New York 2

  • 7/26/2019 UN STI Forum - Urias

    3/11

    Dimensions of access

    Access to

    medicines

    Drug

    availability

    Drug

    affordability

    Drug

    acceptability

    06-06-16 [email protected] - STI Forum, New York 3

  • 7/26/2019 UN STI Forum - Urias

    4/11

    STI are essential for improving availability

    06-06-16 [email protected] - STI Forum, New York 4

  • 7/26/2019 UN STI Forum - Urias

    5/11

    STI are essential for improving affordability

    Crawford, K. W., et al. (2012). Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery inresource-limited settings: a consensus statement. The Lancet infectious diseases, 12(7), 550-560.

    06-06-16 [email protected] - STI Forum, New York 5

  • 7/26/2019 UN STI Forum - Urias

    6/11

    STI are essential for improving acceptability

    06-06-16 [email protected] - STI Forum, New York 6

  • 7/26/2019 UN STI Forum - Urias

    7/11

    But life is not a bed of roses: IPR x Access

    06-06-16 [email protected] - STI Forum, New York 7

  • 7/26/2019 UN STI Forum - Urias

    8/11

    STI-based catch up is needed! (1)

    Use of Compulsory licensing is

    contrained by technological /

    manufacturing capabilities

    06-06-16 [email protected] - STI Forum, New York 8

  • 7/26/2019 UN STI Forum - Urias

    9/11

    STI-based catch up is needed! (2)

    On generics and biosimilars competition of patent expiration

    Price per bottle in Brazil: US$ 2,300

    Patent expiration: 16/11/2013

    Frank, Richard G., and David S. Salkever."Generic entry and the pricing ofpharmaceuticals." Journal of Economics &Management Strategy6.1 (1997): 75-90.

    06-06-16 [email protected] - STI Forum, New York 9

  • 7/26/2019 UN STI Forum - Urias

    10/11

    Systems must meet!

    06-06-16 [email protected] - STI Forum, New York 10

    STI System

    Health System

    Supranational institutional / regulatory famework

    Access-friendly innovations

    Technological catch-up

    STI to accelerate biosimilar approvals

    Regulatory innovations

    de-linking drug prices from access and

    innovation issues

  • 7/26/2019 UN STI Forum - Urias

    11/1106-06-16 [email protected] - STI Forum, New York 11